Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

Condition:   Cutaneous Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Panitumumab-IRDye800;   Drug: Zirconium Zr-89 Panitumumab;   Device: Pinpoint IR IR9000 flourescence imaging system (FIS);   Device: SPY-PHI IR9000 flourescence imaging system (FIS);   Device: Explorer Air camera;   Device: PDE-NEO II camera;   Device: FIS-00 fluorescence imaging system (FIS);   Device: Da Vinci Firefly Imaging System;   Device: IGP-ELVIS-v4 Macroscopic Specimen Imager;   Device: Vevo 3100 LAZR-X;   Device: Pearl Triology Imaging System;   Device: Odyssey CLx Imaging System;   Device: Leica fluorescence microscope
Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
Not yet recruiting

https://ift.tt/2ASTV2h